Table: Stella Pharma -2023/24 parent results

Stella Pharma

10/05/2024 06:00

May 10 (Reuters)- 
          Stella Pharma Corporation 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to        NEXT   
              Mar 31, 2024    Mar 31, 2023    Mar 31, 2025     YEAR     
                 LATEST         YEAR-AGO        COMPANY       COMPANY   
                 RESULTS         RESULTS        FORECAST    H1 FORECAST 
  Sales          269 mln         229 mln        930 mln                 
               (+17.6 pct)    (+128.8 pct)    (+245.1 pct)              
  Operating   loss 760 mln    loss 806 mln    loss 252 mln              
  Recurring   loss 760 mln    loss 775 mln    loss 257 mln              
  Net         loss 763 mln    loss 778 mln    loss 260 mln              
  EPS        loss 24.66 yen  loss 26.97 yen  loss 8.33 yen              
  Ann Div          NIL             NIL            NIL                   
  -Q2 Div          NIL             NIL            NIL                   
  -Q4 Div          NIL             NIL            NIL                   
  
  NOTE - Stella Pharma Corporation. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4888.T